Síndrome de Stevens-Johnson/necrolisis epidérmica tóxica tratado con inmunoglobulinas intravenosas
Authors:
- Manuela YusteMYManuela Yuste
- Juan Sánchez-EstellaJSJuan Sánchez-Estella
- Juan C. SantosJSJuan C. Santos
- M.ª Teresa AlonsoMAM.ª Teresa Alonso
- M.ª Teresa BordelMBM.ª Teresa Bordel
- José L. GutiérrezJGJosé L. Gutiérrez
- Tomás ZamoraTZTomás Zamora
- 1 November 2005
- journal article
- case report
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 96 (9) , 589-592
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Evaluation of the Potential Role of Cytokines in Toxic Epidermal NecrolysisJournal of Investigative Dermatology, 2004
- Analysis of Intravenous Immunoglobulin for the Treatment of Toxic Epidermal Necrolysis Using SCORTENArchives of Dermatology, 2003
- Correlations Between Clinical Patterns and Causes of Erythema Multiforme Majus, Stevens-Johnson Syndrome, and Toxic Epidermal NecrolysisArchives of Dermatology, 2002
- Diffuse morbilliform eruption after consumption of ginkgo biloba supplementJournal of the American Academy of Dermatology, 2002
- High-dose intravenous immunoglobulins: An approach to treat severe immune-mediated and autoimmune diseases of the skinJournal of the American Academy of Dermatology, 2001
- Síndrome de Stevens-Johnson/necrólisis epidérmica tóxicaPiel, 2001
- Uso de inmunoglobulina humana intravenosa en la necrólisis epidérmica tóxicaPiel, 2001
- Drug-Induced Stevens-Johnson Syndrome/Toxic Epidermal NecrolysisAmerican Journal of Clinical Dermatology, 2000
- Treatment of Severe Drug EruptionsThe Journal of Dermatology, 1999
- Use of intravenous immunoglobulin in the treatment of severe cutaneous drug reactions in patients with AIDSJournal of Allergy and Clinical Immunology, 1996